Filing Details
- Accession Number:
- 0000899243-19-006334
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-03-05 21:06:38
- Reporting Period:
- 2019-03-01
- Accepted Time:
- 2019-03-05 21:06:38
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1351288 | Gw Pharmaceuticals Plc | GWPH | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1754122 | Volker Knappertz | Sovereign House, Vision Park, Histon Cambridge X0 CB24 9BZ | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Disposition | 2019-03-01 | 3,732 | $14.46 | 8,736 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Ordinary Shares | Stock Options | Acquisiton | 2019-03-01 | 48,252 | $0.00 | 48,252 | $14.33 |
| Ordinary Shares | Stock Options | Acquisiton | 2019-03-01 | 91,584 | $0.00 | 91,584 | $0.00 |
| Ordinary Shares | Stock Options | Acquisiton | 2019-03-01 | 6,864 | $0.00 | 6,864 | $0.00 |
| Ordinary Shares | Stock Options | Acquisiton | 2019-03-01 | 6,864 | $0.00 | 6,864 | $0.00 |
| Ordinary Shares | Stock Options | Acquisiton | 2019-03-01 | 6,864 | $0.00 | 6,864 | $0.00 |
| Ordinary Shares | Stock Options | Acquisiton | 2019-03-01 | 6,864 | $0.00 | 6,864 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 48,252 | 2022-03-01 | 2029-03-01 | No | 4 | A | Direct |
| 91,584 | 2022-03-01 | 2023-03-15 | No | 4 | A | Direct |
| 6,864 | 2020-03-01 | No | 4 | A | Direct | |
| 6,864 | 2021-03-01 | No | 4 | A | Direct | |
| 6,864 | 2022-03-01 | No | 4 | A | Direct | |
| 6,864 | 2023-03-01 | No | 4 | A | Direct |
Footnotes
- Represented by American Depositary Shares of the Issuer ("ADS"). Each ADS represents twelve ordinary shares of the Issuer.
- The price reported in Column 4 is price per ordinary share converted from price per ADS.
- Granted pursuant to the Issuer's Long-Term Incentive Plan.
- The reported options are options to purchase ADSs.
- The exercise price reported is price per ordinary share converted from price per ADS ($172.01).
- Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.32 U.S. Dollars as of March 1, 2019.
- These stock options will vest automatically on exercisable date.
Billionaire Hedge Funds
